Cite
HARVARD Citation
Schneider, M. et al. (2016). Asymmetric dimethlyarginine directly promotes chronic kidney disease progression: Evidence from a mendelian randomization approach in the GCKD study. Atherosclerosis. pp. e256-e257. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schneider, M. et al. (2016). Asymmetric dimethlyarginine directly promotes chronic kidney disease progression: Evidence from a mendelian randomization approach in the GCKD study. Atherosclerosis. pp. e256-e257. [Online].